EXHIBIT 10.5

CONFIDENTIALITY, NON-COMPETITION AND INTELLECTUAL PROPERTY AGREEMENT (this
“Agreement”), dated as of February 28, 2006 (the “Effective Date”), among
Gentiva Health Services, Inc., a Delaware corporation (“Gentiva”; together with
all subsidiaries of Gentiva, “Parent”), The Healthfield Group, Inc., a Delaware
corporation (“Healthfield”; together with all subsidiaries of Healthfield, the
“Healthfield Group”), (together with the Parent and the Healthfield Group, the
“Companies”) and Tony Strange (“Executive”).

WHEREAS, the Companies are currently engaged in the business of, among other
things, providing comprehensive home health care services.

WHEREAS, Tara Acquisition Sub Corp., a wholly owned subsidiary of Gentiva, has
merged with and into Healthfield (the “Merger”).

WHEREAS, Executive had an employment agreement with the Healthfield Group (the
“Old Employment Agreement”), which Executive acknowledges has been terminated as
of the date hereof, and Executive has a letter severance agreement with the
Companies dated the date hereof (the “Letter Agreement”). In such role,
Executive will receive or has received specific confidential information
relating to the businesses of the Companies, which confidential information is
or was necessary to enable Executive to perform Executive’s duties. Executive
will play or has played a significant role in the development and management of
the businesses of the Companies and has been or will be entrusted with the
Companies’ confidential information relating to the Companies’ customers,
manufacturers, distributors and others.

WHEREAS, Executive is a holder of Healthfield preferred stock and Healthfield
common stock and is receiving significant consideration as a result of the
Merger.

WHEREAS, it is a condition to the closing of the Merger that Executive enter
into this Agreement.

NOW, THEREFORE, it is mutually agreed as follows:

1. Confidentiality.

(a) Executive shall not, during the term of any employment with the Companies or
at any time thereafter, directly or indirectly, divulge, use, furnish, disclose,
exploit or make available to any person or entity, whether or not a competitor
of the Companies, any Unauthorized disclosure of Confidential Information. In
the event that Executive is requested or required (by deposition,
interrogatories, requests for information or documents in legal proceedings,
subpoenas, civil demand or similar process) to disclose any Confidential
Information, Executive will give the Companies prompt written notice of such
request or requirement so that the Companies may seek an appropriate protective
order or other remedy and/or waive compliance with the provisions of this
Agreement, and Executive will cooperate with the Companies’ efforts to obtain
such protective order. In the event that such protective order or other remedy
is not obtained or the Companies waive compliance with the relevant provisions
of this Agreement, Executive is permitted to furnish that Confidential
Information which is legally required to be disclosed and will use his
reasonable efforts to obtain assurances that confidential treatment will be
accorded to such information.

--------------------------------------------------------------------------------

As used herein, the term:

“Confidential Information” shall mean trade secrets, confidential or proprietary
information, and all other information, documents or materials, relating to,
owned, developed or possessed by any of the Companies, whether in tangible or
intangible form. Confidential Information includes, but is not limited to,
(i) financial information, (ii) products, (iii) product and service costs,
prices, profits and sales, (iv) new business, technical or other ideas,
proposals, plans and designs, (v) business strategies, (vi) product and service
plans, (vii) marketing plans and studies, (viii) forecasts, (ix) budgets,
(x) projections, (xi) computer programs, (xii) data bases and the documentation
(and information contained therein), (xiii) computer access codes and similar
information, (xiv) source codes, (xv) know-how, technologies, concepts and
designs, including, without limitation, patent applications, (xvi) research
projects and all information connected with research and development efforts,
(xvii) records, (xviii) business methods and recommendations, (xix) existing or
prospective client, customer, vendor and supplier information (including, but
not limited to, identities, needs, transaction histories, volumes,
characteristics, agreements, prices, identities of individual contacts, and
spending, preferences or habits), (xx) training manuals and similar materials
used by the Companies in conducting its business operations, (xxi) personnel
files of employees, directors and independent contractors of any of the
Companies, (xxii) competitive analyses, (xxiii) contracts with other parties,
(xxiv) product formulations, and (xxv) other confidential or proprietary
information that has not been made available to the trade or general public by
any of the Companies. Confidential Information shall not include any information
that (A) is or becomes generally available to the public or the trade other than
as a result of a disclosure by the Executive in violation of this Agreement or
(B) becomes available to the Executive on a non-confidential basis from a source
other than the Companies which is not prohibited from disclosing such
information to the Executive by a legal, contractual or fiduciary obligation to
the Employer or any other Person.

“Unauthorized” shall mean: (i) in contravention of the policies or procedures of
any of the Companies; (ii) otherwise inconsistent with any measures taken by any
of the Companies to protect its interests in the Confidential Information;
(iii) in contravention of any lawful instruction or directive, either written or
oral, of the board of directors, or an officer or employee of any of the
Companies empowered to issue such instruction or directive; (iv) in
contravention of any duty existing under law or contract; or (v) to the
detriment of any of the Companies; but shall not include any disclosure which is
customary in the normal course of business in the trade and consistent with the
past practice of the Companies.

(b) Executive further agrees to take all reasonable measures to prevent
unauthorized persons or entities from obtaining or using Confidential
Information. Promptly upon termination, for any reason, of Executive’s
employment with the Companies, Executive agrees to deliver to the Companies all
property and materials within Executive’s possession or control which belong to
any of the Companies or which contain Confidential Information.

(c) Nothing in this Section 1 is intended to preclude Executive from using his
general knowledge and know-how regarding the management of a health care service
provider in any future employment or business venture; provided, that
Executive’s use of such general knowledge and know-how does not violate the
provisions of Section 2 hereof.

--------------------------------------------------------------------------------

2. Non-Competition; Non-Solicitation.

(a) For a period of time equal to the later of the fifth anniversary of the
effective date of the Merger or the second anniversary after the termination of
the Executive’s employment with the Companies (the “Noncompete Period”),
Executive will not, directly or indirectly, engage, anywhere in the United
States, whether such engagement be as an individual, officer, director,
proprietor, consultant, employee, partner, member, stockholder, investor (other
than solely as a holder of less than three percent (3%) of the outstanding
capital stock of a corporation whose shares are publicly traded on a national
securities exchange or through a national market system or registered pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as amended), creditor,
consultant, advisor, sales representative, agent or other participant, in a
Restricted Business.

(b) During the Noncompete Period, Executive shall not directly or indirectly
(i) solicit, divert, or entice away any person who is an officer, agent, or
employee of, or consultant or advisor to, any of the Companies to accept
employment or a consultancy with a third party or (ii) hire any current or
future employees of the Companies, unless such person has not been employed by
any of the Companies for not less than 12 months (other than, Lisa Shunnarah).

(c) During the Noncompete Period, Executive shall not solicit or accept on
behalf of yourself or anyone else any of the Companies’ customers and/or clients
with a view to sell or provide any product or service competitive with any
product or service sold or provided or under development by the Companies. For
the purposes of this Agreement, the term “customer” and/or “client” shall
include any person or entity to whom the Companies, through its offices in which
you had direct or indirect oversight and managerial duties during your
employment with the Companies, have sold, provided or been obligated to provide,
any service or product, or who has otherwise received any service or benefit
from the Companies, within 24 months prior to the termination of Executive’s
employment with the Companies.

“Restricted Business” shall mean (i) the business operations operated by the
Companies; (ii) home health services, including but not limited to the provision
of skilled nursing, rehabilitative therapy services (physical, occupational and
speech therapy and social work), home health aid care, and homemaker services to
pediatric, adult, and elderly patients in their homes or places of residence;
(iii) hospice care; (iv) home/durable medical equipment and/or respiratory
services; and (v) infusion therapy.

Notwithstanding the foregoing, nothing in this Section 2 shall prohibit
Executive from (i) owning any amount of stock in Gentiva or serving in any
capacity as an officer, director or employee of Gentiva or (ii) making passive
investments in another entity (e.g. a private equity or debt fund) not
controlled by Executive that makes investments, whether debt or equity, in other
entities that may be engaged in a Restricted Business, provided that Executive
does not directly or indirectly own or control in excess of 10% of any
Restricted Business.

3. Intellectual Property. Executive agrees that during the term of Executive’s
employment with the Companies, any and all inventions, discoveries, innovations,
writings, domain names, improvements, trade secrets, designs, drawings, business
processes, secret

--------------------------------------------------------------------------------

processes and know-how, whether or not patentable or a copyright or trademark,
which Executive may create, conceive, develop or make, either alone or in
conjunction with others and related or in any way connected with any of the
Companies, its strategic plans, products, processes, apparatus or business now
or hereafter carried on by any of the Companies (collectively, “Inventions”),
shall be fully and promptly disclosed to the Companies and shall be the sole and
exclusive property of the Companies (as they shall determine) as against
Executive or any of Executive’s assignees. Regardless of the status of
Executive’s employment by the Companies, Executive and Executive’s heirs,
assigns and representatives shall promptly assign to the Companies any and all
right, title and interest in and to such Inventions made during the term of
Executive’s employment by any of the Companies. Executive represents that there
are no Inventions with respect to any of the Companies conceived of, developed
or made by Executive before the date of this Agreement which have not been
disclosed to and assigned to the Companies.

Whether during or after Executive’s employment with the Companies, Executive
further agrees to execute and acknowledge all papers and to do, at the
Companies’ expense, any and all other things necessary for or incident to the
applying for, obtaining and maintaining of such letters patent, copyrights,
trademarks or other intellectual property rights, as the case may be, and to
execute, on request, all papers necessary to assign and transfer such
Inventions, copyrights, patents, patent applications and other intellectual
property rights to the Companies, their successors and assigns (as they shall
determine). In the event that the Companies are unable, after reasonable efforts
and, in any event, after thirty (30) business days, to secure Executive’s
signature on a written assignment to the Companies, of any application for
letters patent, trademark registration or to any common law or statutory
copyright or other property right therein to which the Companies are entitled to
ownership pursuant to this Section 3, whether because of his physical or mental
incapacity, or for any other reason whatsoever, Executive irrevocably designates
and appoints the Secretary or any Assistant Secretary of the Parent as
Executive’s attorney-in-fact to act on Executive’s behalf to execute and file
any such applications and to do all lawfully permitted acts to further the
prosecution or issuance of such assignments, letters patent, copyright or
trademark; provided, however, that the provisions of this sentence shall not
apply if the Executive disputes in writing the Companies’ ownership of the
intellectual property rights which are the subject of the proposed assignment.

4. Non-Disparagement. Executive shall not make any false, defamatory or
disparaging statements about any of the Companies or any of its officers,
directors and employees. No officer or director of the Parent shall make any
false, defamatory or disparaging statements about the Executive.

5. No Right to Continued Employment. Nothing in this Agreement shall confer upon
Executive any right to continue in the employ of the Companies or shall
interfere with or restrict in any way the rights of the Companies, which,
subject to the terms of the Letter Agreement, are hereby reserved, to discharge
Executive at any time for any reason whatsoever, with or without cause.

6. No Conflicting Agreements. Executive warrants that Executive is not bound by
the terms of a confidentiality agreement, non-competition or other agreement
with a third party that would conflict with Executive’s obligations hereunder.

--------------------------------------------------------------------------------

7. Remedies. The period of time during which the restrictions set forth in
Section 2(a) hereof will be in effect will be extended by the length of time
during which Executive is in breach of the terms of those provisions as finally
determined by any court of competent jurisdiction.

8. Successors and Assigns. This Agreement shall be binding upon Executive and
Executive’s heirs, assigns and representatives and inure to the benefit of the
Companies and their successors and assigns, including without limitation any
entity to which substantially all of the assets or the business of any of the
Companies are sold or transferred. The obligations of Executive are personal to
Executive and shall not be assigned by Executive. The Companies may assign its
rights under this Agreement to any affiliate of the Companies that employs
Executive.

9. Severability. It is expressly agreed that if any restrictions set forth in
this Agreement are found by any court having jurisdiction to be unreasonable
because they are too broad in any respect, then and in each such case, the
remaining provisions herein contained shall, nevertheless, remain effective, and
this Agreement, or any portion hereof, shall be considered to be amended, so as
to be considered reasonable and enforceable by such court, and the court shall
specifically have the right to restrict the time period or the business or
geographical scope of such restrictions to any portion of the time period,
business or geographic areas to the extent the court deems such restriction to
be necessary to cause the covenants to be enforceable and, in such event, the
covenants shall be enforced to the extent so permitted and the remaining
provisions shall be unaffected thereby. In such event, the parties hereto agree
to execute all documents necessary to evidence such amendment so as to eliminate
or modify any such unreasonable provision in order to carry out the intent of
this Agreement insofar as possible and to render this Agreement enforceable in
all respects as so modified. The covenants contained in this Section 9 shall be
construed to extend to separate jurisdictions or subjurisdictions of the United
States in which the Companies, during the term of Executive’s employment, have
been or are engaged in business, and to the extent that any such covenant shall
be illegal and/or unenforceable with respect to any jurisdiction, said covenant
shall not be affected thereby with respect to each other jurisdiction, such
covenants with respect to each jurisdiction being construed as severable and
independent. Any covenant on Executive’s part contained hereinabove, which may
not be specifically enforceable, shall nevertheless, if breached, give rise to a
cause of action for monetary damages. The restrictive covenant provisions of
this Agreement shall govern to the extent there is any conflict between their
terms and the terms of any other agreement or understanding with the Companies.

10. Notices. All notices and other communications under this Agreement shall be
in writing and shall be deemed given (i) when delivered personally by hand (with
written confirmation of receipt), (ii) when sent by facsimile (with written
confirmation of transmission) or (iii) one Business Day following the day sent
by overnight courier (with written confirmation of receipt), in each case at the
following addresses and facsimile numbers (or to such other address or facsimile
number as a party may have specified by notice given to the other party pursuant
to this provision):

--------------------------------------------------------------------------------

If to the Companies, to:    with a copy to:

Gentiva Health Services, Inc.

3 Huntington Quadrangle, Suite 200S

Melville, NY 11747-4627

Attention: Stephen B. Paige, General Counsel

Facsimile: (913) 814-5920

  

Weil, Gotshal & Manges LLP

767 Fifth Avenue

New York, NY 10153

Attention: Jeffrey J. Weinberg, Esq.

Facsimile: (212) 310-8007

If to the Executive, to:   

Executive’s address set forth

beneath Executive’s

signature on this Agreement.

  

Greenberg Traurig

The Forum

3290 Northside Parkway, NW

Suite 1400

Atlanta, GA 30327

Attention: Gary Snyder, Esq.

Facsimile: (678) 553-2212

11. Amendment. No provision of this Agreement may be modified, amended, waived
or discharged in any manner except by a written instrument executed by the
Companies and Executive.

12. Entire Agreement. This Agreement constitutes the entire agreement of the
parties hereto with respect to the subject matter hereof, and supersedes all
prior agreements and understandings of the parties hereto, oral or written, with
respect to the subject matter hereof.

13. Waiver, etc. The failure of the Companies to enforce at any time any of the
provisions of this Agreement shall not be deemed or construed to be a waiver of
any such provision, nor in any way affect the validity of this Agreement or any
provision hereof or the right of the Companies to enforce thereafter each and
every provision of this Agreement. No waiver of any breach of any of the
provisions of this Agreement by the Companies shall be effective unless set
forth in a written instrument executed by the Companies, and no waiver of any
such breach shall be construed or deemed to be a waiver of any other or
subsequent breach.

14. Applicable Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York applicable to contracts made
and to be wholly performed therein without reference to conflicts of law
principles, except as otherwise provided.

15. Enforcement. If any party shall institute legal action to enforce or
interpret the terms and conditions of this Agreement or to collect any monies
under it, venue for any such action shall be the State of New York. Each party
irrevocably consents to the jurisdiction of the courts located in the State of
New York for all suits or actions arising out of this Agreement. Each party
hereto waives to the fullest extent possible, the defense of an

--------------------------------------------------------------------------------

inconvenient forum, and each agrees that a final judgment in any action shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment or
in any other manner provided by law.

[Next Page is Signature Page]

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of
the day written above.

 

GENTIVA HEALTH SERVICES, INC.

By:

 

/s/ John R. Potapchuk

Name:

  John R. Potapchuk

Title:

  Senior Vice President, Chief Financial Officer and Treasurer THE HEALTHFIELD
GROUP, INC.

By:

 

/s/ John R. Potapchuk

Name:

  John R. Potapchuk

Title:

  Senior Vice President, Chief Financial Officer and Treasurer TONY STRANGE

/s/ Tony Strange

Tony Strange 3350 Riverwood Parkway Suite 1400 Atlanta, GA 30339